Japanese gynecological benign tumor market is thriving with cutting-edge diagnostic technologies and minimally invasive ...

Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced that it will present posters highlighting new ...